BioSpace News Archive

Willow Biosciences Inc. has released its financial and operating results for the three months ended June 30, 2022, reporting significant progress to its operational platform, leadership and strong liquidity.

MediPharm Labs Corp. today announced its financial results for the three and six months ended June 30, 2022.

Acurx Pharmaceuticals, Inc. announced today certain financial and operational results for the quarter ended June 30 , 2022.

BrainStorm Cell Therapeutics today announced financial results for the second quarter ended June 30, 2022, and provided a corporate update.

LogicBio® Therapeutics, Inc. (NASDAQ: LOGC), a clinical-stage genetic medicine company, today reported financial results for the second quarter ended June 30, 2022, and provided business updates, including early clinical data from its ongoing SUNRISE trial evaluating LB-001 in pediatric patients with severe methylmalonic acidemia (MMA).

Virios Therapeutics, Inc. today announced commencement of enrollment in its exploratory Long-COVID trial.

BeiGene today announced a strategic agreement with Ontada® to improve U.S. community oncology care through the development of real-world evidence (RWE) data, tools, and insights to help increase access to affordable, cutting-edge therapies.

Gamida Cell today provided a business update and reported financial results for the quarter ended June 30, 2022.

Gelesis (NYSE: GLS), the maker of Plenity for weight management, today reported financial results for the second quarter of 2022.

Antibe Therapeutics Inc has filed its financial and operating results for the fiscal quarter ended June 30, 2022.